Concepedia
Statistics
Publications
23
Citations
5.1K
H-Index
19
Active since
1979
Affiliations
AbbVie (United States)(Current)
Walter and Eliza Hall Institute of Medical Research
The University of Melbourne
Abbott Fund
University of Alberta
Chris Tse is an author at AbbVie (United States) specializing in pharmacology, medicinal chemistry, and medicine.
Publications per year
1979–2023
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers, Joel D. Leverson, Erwin R. Boghaert et al. · Nature Medicine · 2013 · 3K citations
Medicine, Oncology, Pharmacology +10
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
Joel D. Leverson, Darren C. Phillips, Michael J. Mitten et al. · Science Translational Medicine · 2015 · 541 citations · Full text
Medicine, Oncology, Pharmacology +14
Discovery of a Potent and Selective BCL-X <sub>L</sub> Inhibitor with <i>in Vivo</i> Activity
Zhi‐Fu Tao, Lisa Hasvold, Le Wang et al. · ACS Medicinal Chemistry Letters · 2014 · 331 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +10
Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a
Ramzi F. Sweis, Marina Pliushchev, Peter J. Brown et al. · ACS Medicinal Chemistry Letters · 2014 · 185 citations · Full text
Life Sciences, Biochemistry, Medicinal Chemistry +16
Souers AJ, Leverson JD, Boghaert ER et al.ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 19:202-208
Andrew J. Souers, Erwin R. Boghaert, Scott Ackler et al. · 2013 · 182 citations
Medicine, Oncology, Pharmacology +8
1–5 of 23